A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms

NCT07200479 ↗

Phase 1 Not yet recruiting 20 enrolled Institute of Hematology & Blood Diseases Hospital, China

NaSingle-groupOpen-labelTreatment

Summary

A Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1194D CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms

Timeline

Start: 2025-10-30
Primary completion: 2027-06-28
Completion: 2027-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CT1194D	Cell therapy	—	—

A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms

Summary

Timeline

Drugs

Indications